BioCentury | Jan 7, 2021
Deals
Jan. 6 Quick Takes: Ribometrix gets $25M up front in Genentech RNA deal; plus Dewpoint-Pfizer, Kite-Oxford BioTherapeutics, Illumina-Helix and more
...discovery, clinical and regulatory milestones, plus royalties.Illumina, Helix...
...for new SARS-CoV-2 variantsIllumina Inc. (NASDAQ:ILMN) and Helix...
...for new SARS-CoV-2 variantsIllumina Inc. (NASDAQ:ILMN) and Helix...